Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.56 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.37 |
| ▸ | HTR7 | P34969 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL346226 | 1.00 | ESR1 (0.56) | ESR1ESR2PDK2L3MBTL1HPGD | |
| SCHEMBL30314588 | 1.00 | ESR1 (0.56) | ESR1ESR2PDK2L3MBTL1HPGD | |
| SCHEMBL9095583 | 0.94 | ESR1 (0.50) | ESR1ESR2PDK2L3MBTL1HPGD | |
| SCHEMBL29506867 | 0.93 | ESR1 (0.55) | ESR1ESR2PDK2L3MBTL1HPGD | |
| SCHEMBL383359 | 0.93 | ESR1 (0.55) | ESR1ESR2PDK2L3MBTL1HPGD | |
| SCHEMBL22558054 | 0.92 | ESR1 (0.51) | ESR1ESR2PDK2L3MBTL1HPGD | |
| SCHEMBL31099331 | 0.92 | ESR1 (0.54) | ESR1ESR2PDK2L3MBTL1HPGD | |
| SCHEMBL382593 | 0.92 | ESR1 (0.54) | ESR1ESR2PDK2L3MBTL1HPGD | |
| SCHEMBL26983396 | 0.89 | ESR1 (0.59) | ESR1ESR2PDK2L3MBTL1HPGD | |
| SCHEMBL22187631 | 0.89 | ESR1 (0.44) | ESR1ESR2PDK2L3MBTL1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115703883-B | Catalyst and preparation method of polycarbonate | 华为技术有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-115703883-A | Catalyst and preparation method of polycarbonate | 华为技术有限公司 | 2023-02-17 | — | — | CN | claimed |
| CN-112250852-B | Polycarbonate resin, preparation method and formed optical component | 万华化学集团股份有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-122055347-A | Oligomeric binaphthyl compounds and thermoplastic resins | 三菱瓦斯化学株式会社 | 2026-05-15 | — | — | CN | disclosed |
| US-20260070867-A1 | BINAPHTHYL COMPOUNDS AND THERMOPLASTIC RESINS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-03-12 | — | — | US | disclosed |
| US-20260015483-A1 | DEPOLYMERIZATION METHOD FOR RESIN HAVING FLUORENE SKELETON, AND PRODUCT AND APPLICATION THEREOF | OSAKA GAS CHEMICALS CO., LTD. (JP) | 2026-01-15 | — | — | US | disclosed |
| EP-4046984-B1 | COMPOUND, RESIN, POLYCARBONATE RESIN, AND OPTICAL MOLDED BODY | MITSUI CHEMICALS INC (JP) | 2025-09-03 | — | — | EP | disclosed |
| US-12384132-B2 | Retardation film and method for producing same | OSAKA GAS CHEMICALS CO., LTD. (JP) | 2025-08-12 | — | — | US | disclosed |
| EP-4594286-A1 | OLIGOMERIC BINAPHTYL COMPOUNDS AND THERMOPLASTIC RESINS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-08-06 | — | — | EP | disclosed |
| CN-111499896-B | Substrate for transparent conductive film and transparent conductive film | 日东电工株式会社 | 2025-06-03 | — | — | CN | disclosed |
| CN-119998360-A | Thermoplastic resin and molded body comprising thermoplastic resin | 三菱瓦斯化学株式会社 | 2025-05-13 | — | — | CN | disclosed |
| US-20220243045-A1 | THERMOPLASTIC RESIN COMPOSITION, MOLDED ARTICLE, AND PRODUCT | MITSUBISHI ELECTRIC CORPORATION (JP) | 2022-08-04 | — | — | US | disclosed |
| US-11332614-B2 | Reinforced polycarbonate resin composition | TEIJIN LIMITED (JP) | 2022-05-17 | — | — | US | disclosed |
| WO-2022091780-A1 | THERMOPLASTIC RESIN AND OPTICAL MEMBER INCLUDING SAME | 帝人株式会社 | 2022-05-05 | — | — | WO | disclosed |
| WO-2022075328-A1 | POLYCARBONATE RESIN COMPOSITION AND CIRCUIT MOLDED ARTICLE FOR COMMUNICATION DEVICES | 帝人株式会社 | 2022-04-14 | — | — | WO | disclosed |
| WO-2022070729-A1 | PHASE DIFFERENCE FILM AND PRODUCTION METHOD THEREOF | 日本ゼオン株式会社 | 2022-04-07 | — | — | WO | disclosed |
| WO-2022065331-A1 | PRODUCTION METHOD FOR POLYSILOXANE, COMPOSITION INCLUDING POLYSILOXANE, AND MOLDED BODY | 三菱瓦斯化学株式会社 | 2022-03-31 | — | — | WO | disclosed |
| WO-2022065327-A1 | COMPOSITION AND SILOXANE-BASED THERMOPLASTIC RESIN USING SAME, AND METHODS FOR PRODUCING SAME | 三菱瓦斯化学株式会社 | 2022-03-31 | — | — | WO | disclosed |
| EP-3647369-B1 | REINFORCED POLYCARBONATE RESIN COMPOSITION | TEIJIN LTD (JP) | 2022-03-16 | — | — | EP | disclosed |
| CN-114072461-A | Thermoplastic resin composition, molded article, and product | 三菱电机株式会社 | 2022-02-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070867-A1 | BINAPHTHYL COMPOUNDS AND THERMOPLASTIC RESINS | CBR1, CBR3, SCO2 | ESR1 1558/4885ESR2 324/4885PDK2 3910/4885 |
| US-20260015483-A1 | DEPOLYMERIZATION METHOD FOR RESIN HAVING FLUORENE SKELETON, AND PRODUCT AND APPLICATION THEREOF | PARG, FTO, FRG1 | ESR1 1645/4885ESR2 2074/4885PDK2 989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.